Skip to content
Screener

Prestige Consumer Healthcare PBH International OTC Healthcare — Cost of Sales

Other segment segments

North American OTC Healthcare
$110.27M+19.6%

Similar metrics at other companies

Daktronics logo
DAKTInternational — Cost of Sales
$10.7M-19.6%
Walmart logo
WMTWalmart International — Cost of Sales
$27.69B+18.0%
Sysco logo
SYYInternational Foodservice Operations — Cost of Sales
$3.05B+11.8%
ALH
ALHInternational — Cost of Sales
$64.72M+10.6%
Hershey logo
HSYInternational — Cost of Sales
$182.74M+23.1%
Keurig Dr Pepper logo
KDPInternational — Cost of Sales
$290M+27.2%

Other financials

Income statement

See full
Revenue$265.7M+6.5%
Gross profit$136.2M-3.0%
Operating income$52.5M-26.8%
Net income$29.2M-38.5%
EPS (diluted)$0.61-35.8%

Balance sheet

See full
Cash & equivalents$89.1M-36.1%
Total debt$2.1B+97.4%
Total equity$1.9B+3.3%
Total assets$4.6B+33.1%

Cash flow

See full
Operating cash flow$70.8M-10.4%
CapEx$3.7M+342%
Free cash flow$67.1M-14.2%

Valuation

See full
Market cap$2.58B-30.3%
Enterprise value$4.55B-1.2%
P/E15×-2.4×
P/S2.3×-1.0×

Profitability

See full
Gross margin53.5%-2.6pp
Operating margin26.3%-3.8pp
Net margin15.6%-3.4pp
FCF margin21.3%-2.6pp

Returns & leverage

See full
Return on equity9.1%-2.9pp
Debt / equity1.1×+0.5×
Current ratio3.2×-1.2×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:CostOfRevenue.

The source filing: Prestige Consumer Healthcare’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:15 AM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001295947-26-000042
(In thousands)Three Months Ended June 30, 2026 / North American OTCHealthcareThree Months Ended June 30, 2026 / International OTCHealthcareConsolidated
Total segment revenues*$226,206$39,504$265,710
Cost of sales110,26519,257129,522
Gross profit115,94120,247136,188
Advertising and marketing28,9305,73834,668
Contribution margin$87,011$14,509$101,520
Other operating expenses49,000
Operating income$52,520
* Intersegment revenues of $0.7 million were eliminated from the North American OTC Healthcare segment.

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Prestige Consumer Healthcare's international OTC healthcare — cost of sales?
Prestige Consumer Healthcare (PBH) reported international OTC healthcare — cost of sales of $19.26M in Q2 2026.
How has Prestige Consumer Healthcare's international OTC healthcare — cost of sales changed year-over-year?
Prestige Consumer Healthcare's international OTC healthcare — cost of sales increased by 13.1% year-over-year, from $17.02M to $19.26M.
What is the long-term trend for Prestige Consumer Healthcare's international OTC healthcare — cost of sales?
Over 4 years (2022 to 2026), Prestige Consumer Healthcare's international OTC healthcare — cost of sales has grown at a 14.4% compound annual growth rate (CAGR), from $47M to $80.43M.
What does international OTC healthcare — cost of sales mean?
This represents the direct costs attributable to the production and distribution of over-the-counter healthcare products within the international segment. It includes raw materials, manufacturing labor, and logistics expenses required to bring products to market. Monitoring this helps assess the production efficiency and cost structure of international operations.

Ask your AI about Prestige Consumer Healthcare's international otc healthcare — cost of sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude